| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.001 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.78 | 0.003 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.091 | 0.004 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.15 | 0.007 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.008 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.17 | 0.008 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |